Clinical Trials

Home » Clinical Trials

Phase II Trials Outnumbered All Other Trials in 2017

A quarterly analysis of clinical trials with a start date in 2017, found that Phase II trials outnumbered all other trials by contributing between 45% and 48% across the period, according to leading data and analytics company, GlobalData. The share of Phase I trials started at 17% in the first quarter and continued to increase [...]

Children Could be Excluded from Lifesaving Clinical Trials When UK Leaves EU

Children could be excluded from lifesaving clinical trials for cancer treatments when the UK leaves the EU, according to the Brexit Health Alliance. In a briefing paper, the alliance of organisations from the NHS, medical research, industry, patients and public health organisations, is calling on both sides in the Brexit negotiations to put patients first. [...]

Clintec Expands Capabilities with the Accreditation of the Latest Generation of Medidata Rave EDC

Clintec International, an award winning, global clinical research organisation (CRO), enhances its data management capabilities to include Medidata’s latest generation of RAVE EDC (electronic data capture) to ensure superior operational efficiency and advanced functionality. We at Clintec are pleased to announce further expansion of our partnership with Medidata. Clintec received accreditation in RAVE EDC, upgrading [...]

Majority of Oncology Clinical Trials in China Failed to Meet Enrolment Targets

The majority of oncology clinical trials in China that had a start date between 1 January 2012 and 31 December 2017 failed to meet the planned enrolment targets, according to GlobalData, a leading data and analytics company. The company identified and analysed enrolment efficiencies of 324 clinical trials during the period and found that on [...]

ERT Expands Respiratory Solutions to Support New Endpoints

ERT, a global data and technology company that minimises uncertainty and risk in clinical trials, has announced advanced respiratory clinical trial services that centrally collect lung function data using the Forced Oscillation Technique (FOT). This solution is available immediately for trials of asthma, COPD and other respiratory conditions. Used in combination with FEV1 and other [...]

Positive Results Achieved in ReViral’s Phase IIa RSV Challenge Study

  Eddy Littler, CEO of ReViral ReViral, a UK-based biotech company focused on developing novel compounds targeting respiratory syncytial virus (RSV), has announced successful results from its Phase IIa placebo-controlled challenge trial in healthy adult subjects infected intranasally with respiratory syncytial virus (RSV). The study of RV521, an oral RSV fusion inhibitor, achieved all [...]

CluePoints Wins Best Risk-Based Monitoring Solution in 2018 Biotechnology Awards

CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has been honoured in this year’s Biotechnology Awards with the CluePoints solution being named the “Best Risk-Based Monitoring Solution.” The Biotechnology Awards recognise the key players and companies that are driving the industry forward with game-changing advances and revolutionary [...]

ERT Showcased for Improving Patient Engagement in Clinical Trials

ERT, a global data and technology company that minimises uncertainty and risk in clinical trials, has announced that Karin Beckstrom, who heads up the company’s Innovation Lab, has been named a Top 20 Innovator by CenterWatch. CenterWatch’s list of Top 20 Innovators recognises the smart and talented industry representatives who are exploring and developing innovative products and [...]

BiondVax Plans Phase III Clinical Trial Following Receipt of Scientific Advice from EMA

BiondVax Pharmaceuticals Ltd has announced that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) reviewed BiondVax's Phase III trial plan, provided advice and allowed the company to proceed with the Phase III clinical trial plan for M-001, BiondVax's universal flu vaccine candidate. The CHMP advice will facilitate procedures in the countries [...]

Clinical Trial Transparency Reaches Highest Recorded Level

Timely reporting of results from pharmaceutical company sponsored clinical trials for newly approved medicines has reached the highest recorded level of 93%, according to a new study published in the peer-reviewed journal Current Medical Research and Opinion (CMRO). The ABPI-sponsored study – Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials [...]